News

Filter

Current filters:

None

Popular Filters

7975 to 7999 of 8825 results

UCB pulls out of Biotie partnership on SYN118

25-11-2011

Finland-based Biotie Therapies (Nasdaq-OMX: BTH1V) says that, as it had already expected following disappointing…

Biotie TherapiesLicensingNeurologicalPharmaceuticalUCB

Amgen’s gets new US patent for Enbrel, giving protection until 2028

24-11-2011

Global biotech leader Amgen (Nasdaq: AMN) has announced the issuance of a new patent, US Patent No 8,063,182,…

AmgenAnti-Arthritics/RheumaticsBiotechnologyEnbrelNorth AmericaPatentsPharmaceuticalRoche

Key hospital-infections markets set to grow to over $4 billion in 2020; report

24-11-2011

Despite market constraints that include intensified competition, generic erosion and an increasingly…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceutical

Denmark’s Novo Nordisk partners to tackle Qatar’s diabetes problem

24-11-2011

According to Danish insulin giant Novo Nordisk (NVO: N) diabetes is on the rise in Qatar and poses a…

DiabetesHealthcareNovo NordiskPharmaceuticalRest of the World

FDA approves Transcept Pharma’s Intermezzo mid-night insomnia treatment

24-11-2011

US drugmaker Transcept Pharmaceuticals (Nasdaq: TSPT) saw its shares jump 11% to $7.34 yesterday, after…

IntermezzoNeurologicalNorth AmericaPharmaceuticalPurdue PharmaRegulationTranscept Pharmazolpidem

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region

24-11-2011

Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

UK’s NICE gives preliminary “no” to Novartis’ Lucentis for macular edema

24-11-2011

In preliminary recommendations published today (November) 24 by the UK drugs watchdog the National Institute…

EuropeLucentisNovartisOphthalmicsPharmaceuticalPricingRegulation

Asahi Kasei Pharma expands into USA with acquisition of Artisan Pharma

24-11-2011

Mid-size Japanese drugmaker Asahi Kasei Pharma says it has acquired its US licensee Artisan Pharma, establishing…

Artisan PharmaAsahi KaseiMergers & AcquisitionsPharmaceuticalRecomodulin

Celgene to drop Revlimid in CR prostate cancer following Ph III trial failure

23-11-2011

There was disappointment for blockbuster for multiple myeloma drug Revlimid (lenalidomide) when the Swiss…

BiotechnologyCelgeneOncologyPharmaceuticalResearchRevlimid

Problems identified in Canada’s drug regulatory system

23-11-2011

A report presented to the Canadian Parliament this week by John Wiersema, Interim Auditor General of…

North AmericaPharmaceuticalRegulation

EMA makes interim recommendations to deal with shortcomings at Ben Venue Labs

23-11-2011

The European Medicines Agency (EMA) is currently reviewing shortcomings in quality assurance identified…

Boehringer IngelheimEuropeMarkets & MarketingNorth AmericaPharmaceuticalRegulation

Indian HIV drugs market forecast to reach $54 million by 2014

23-11-2011

The market for HIV drugs in India is expected to reach 454 million by 2014, according to a new report…

Anti-viralsAsia-PacificGenericsMarkets & MarketingPharmaceutical

Merck & Co to pay $950 million for illegal marketing of Vioxx

23-11-2011

US pharma giant Merck & Co (NYSE: MRK) has agreed to pay $950 million to resolve criminal charges and…

FinancialLegalMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalVioxx

Pfizer to buy Excaliard, gaining rights to Ph II skin scarring product

23-11-2011

Global pharma behemoth Pfizer (NYSE: PFE) says it has entered into a definitive agreement to acquire…

DermatologicalsExcaliard PharmaIsis PharmaceuticalsMergers & AcquisitionsPfizerPharmaceutical

UCB adds to CNS portfolio with acquisition of Lectus’ key pharmaceutical assets

23-11-2011

Belgian drugmaker UCB (Euronext Brussels: UCB) has acquired the key pharmaceutical assets of closely-held,…

Lectus TherapeuticsMergers & AcquisitionsNeurologicalPharmaceuticalResearchUCB

FDA accepts NDA for Lundbeck and Otsuka’s aripiprazole depot formulation

23-11-2011

Danish CNS drug specialist Lundbeck (LUND: DC) and its new partner Japan’s Otsuka Pharmaceutical…

aripiprazole depotLundbeckNeurologicalNorth AmericaOtsukaPharmaceuticalRegulation

Novartis gains NIH listing in Japan for Ilaris

23-11-2011

Swiss drug major Novartis’ (NOVN: VX) Ilaris (canakinumab), a treatment for cryopyrin-associated…

Anti-Arthritics/RheumaticsAsia-PacificIlarisNovartisPharmaceuticalPricingRare diseases

Andromeda’s type 1 diabetes candidate DiaPep277 meets Ph III primary endpoint

22-11-2011

Israel-based Andromeda Biotech, a subsidiary of Clal Biotechnology Industries (TASE: CBI.TA), says initial…

AndromedaBiotechnologyClal BiotechnologyDiabetesDiaPep277ResearchTeva Pharmaceutical Industries

Promotions at Par Pharma as firm grows with acquisitions

22-11-2011

US generics drugmaker Par Pharmaceutical (NYSE: PRX) has promoted Thomas Haughey to the role of president…

GenericsManagementPar Pharmaceutical

7975 to 7999 of 8825 results

Back to top